AI in Health Care: Balancing Benefits and Barriers
AI can help alleviate the burden on clinical labs—but only with sufficient investment, enthusiasm, and understanding
Keeps You Up-to-Date on New Diagnostic Tests, Testing Trends and Opportunities, and Emerging Test Technologies
AI can help alleviate the burden on clinical labs—but only with sufficient investment, enthusiasm, and understanding
Automation software uses advanced computational tools to generate gapless genome sequences in just a couple of days.
Although PRS technology and adoption still have a way to go, it is progressing quickly, especially in the cancer and oncology space.
Free open-source software can be leveraged across diagnostic processes—how can your organization benefit from it?
Christian Olsen, a leader in R&D scientific software, discusses recent developments related to AI and solutions to current precision medicine challenges.
In early May, GSK’s Arexvy became the first RSV vaccine to be cleared by the FDA for use in the US in adults aged 60 and up.
AAV2 virus detected with metagenomics, TE sequencing, and PCR in non-A–E hepatitis cases from two cohorts in Scotland/the UK and the US.
A simple blood test may help screen, identify, intervene, treat, monitor, and eventually, prevent PTSD.
New research suggests that the call to rein in low-value prostate cancer screening seems to be falling on deaf ears.
Health inequities and disrupted STI testing and care during the pandemic continued to contribute to a rise in cases in 2021.
Though there are currently no clinical guidelines for their use, PRSs are being widely used in health care.